164 related articles for article (PubMed ID: 10498534)
1. Planting the seeds of new antimalarial drugs.
Ridley RG
Science; 1999 Sep; 285(5433):1502-3. PubMed ID: 10498534
[No Abstract] [Full Text] [Related]
2. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.
Jomaa H; Wiesner J; Sanderbrand S; Altincicek B; Weidemeyer C; Hintz M; Türbachova I; Eberl M; Zeidler J; Lichtenthaler HK; Soldati D; Beck E
Science; 1999 Sep; 285(5433):1573-6. PubMed ID: 10477522
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiplasmodial activity of highly active reverse analogues of the antimalarial drug candidate fosmidomycin.
Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Gräwert T; Groll M; Rohdich F; Bacher A; Eisenreich W; Fischer M; Maes L; Kurz T
ChemMedChem; 2010 Oct; 5(10):1673-6. PubMed ID: 20718073
[No Abstract] [Full Text] [Related]
4. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
[TBL] [Abstract][Full Text] [Related]
5. Tools for discovery of inhibitors of the 1-deoxy-D-xylulose 5-phosphate (DXP) synthase and DXP reductoisomerase: an approach with enzymes from the pathogenic bacterium Pseudomonas aeruginosa.
Altincicek B; Hintz M; Sanderbrand S; Wiesner J; Beck E; Jomaa H
FEMS Microbiol Lett; 2000 Sep; 190(2):329-33. PubMed ID: 11034300
[TBL] [Abstract][Full Text] [Related]
6. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2005 Jul; 338(7):305-14. PubMed ID: 15996004
[TBL] [Abstract][Full Text] [Related]
7. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
Wiesner J; Ortmann R; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
[TBL] [Abstract][Full Text] [Related]
8. The malarial drug target Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (PfDXR): development of a 3-D model for identification of novel, structural and functional features and for inhibitor screening.
Goble JL; Adendorff MR; de Beer TA; Stephens LL; Blatch GL
Protein Pept Lett; 2010 Jan; 17(1):109-20. PubMed ID: 20214634
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
[TBL] [Abstract][Full Text] [Related]
10. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
Proteau PJ
Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of phosphonated N-heteroarylcarboxamides as DOXP-reductoisomerase (DXR) inhibitors.
Bodill T; Conibear AC; Blatch GL; Lobb KA; Kaye PT
Bioorg Med Chem; 2011 Feb; 19(3):1321-7. PubMed ID: 21216609
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
Tahar R; Basco LK
Am J Trop Med Hyg; 2007 Aug; 77(2):214-20. PubMed ID: 17690389
[TBL] [Abstract][Full Text] [Related]
13. Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomerase.
Perruchon J; Ortmann R; Altenkämper M; Silber K; Wiesner J; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1232-41. PubMed ID: 18470849
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial activity of N(6)-substituted adenosine derivatives. Part 3.
Herforth C; Wiesner J; Heidler P; Sanderbrand S; Van Calenbergh S; Jomaa H; Link A
Bioorg Med Chem; 2004 Feb; 12(4):755-62. PubMed ID: 14759735
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided design and biosynthesis of a novel FR-900098 analogue as a potent Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr) inhibitor.
Cobb RE; Bae B; Li Z; DeSieno MA; Nair SK; Zhao H
Chem Commun (Camb); 2015 Feb; 51(13):2526-8. PubMed ID: 25567100
[TBL] [Abstract][Full Text] [Related]
16. Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.
Kuntz L; Tritsch D; Grosdemange-Billiard C; Hemmerlin A; Willem A; Bach TJ; Rohmer M
Biochem J; 2005 Feb; 386(Pt 1):127-35. PubMed ID: 15473867
[TBL] [Abstract][Full Text] [Related]
17. Towards new antimalarial drugs: synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.
Giessmann D; Heidler P; Haemers T; Van Calenbergh S; Reichenberg A; Jomaa H; Weidemeyer C; Sanderbrand S; Wiesner J; Link A
Chem Biodivers; 2008 Apr; 5(4):643-56. PubMed ID: 18421757
[TBL] [Abstract][Full Text] [Related]
18. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Reichenberg A; Wiesner J; Weidemeyer C; Dreiseidler E; Sanderbrand S; Altincicek B; Beck E; Schlitzer M; Jomaa H
Bioorg Med Chem Lett; 2001 Mar; 11(6):833-5. PubMed ID: 11277531
[TBL] [Abstract][Full Text] [Related]
19. MEPicides: α,β-Unsaturated Fosmidomycin Analogues as DXR Inhibitors against Malaria.
Wang X; Edwards RL; Ball H; Johnson C; Haymond A; Girma M; Manikkam M; Brothers RC; McKay KT; Arnett SD; Osbourn DM; Alvarez S; Boshoff HI; Meyers MJ; Couch RD; Odom John AR; Dowd CS
J Med Chem; 2018 Oct; 61(19):8847-8858. PubMed ID: 30192536
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of cyclopropyl analogues of fosmidomycin as potent Plasmodium falciparum growth inhibitors.
Devreux V; Wiesner J; Goeman JL; Van der Eycken J; Jomaa H; Van Calenbergh S
J Med Chem; 2006 Apr; 49(8):2656-60. PubMed ID: 16610809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
